Cell And Gene Therapy Manufacturing

  1. AAV Purification: Solving Downstream Challenges 6/9/2025

    In this roundtable discussion, a trio of distinguished experts in AAV purification and process development share their expertise and best practices in tackling and solving downstream challenges.

  2. DoE Methodology For Downstream Purification Of pDNA Of IEX Resins 6/16/2025

    Learn a systematic approach using Design of Experiment to optimize plasmid DNA purification. See how anion exchange resins are evaluated to enhance dynamic binding capacity and process efficiency.

  3. Cell Therapy Bioprocessing Workflow Cinematic 5/28/2025

    Witness a seamless cell therapy bioprocessing workflow that reduces manufacturing time and preserves the crucial cell phenotype for scalable, effective autologous and allogeneic therapies.

  4. Upstream To Downstream: A Comprehensive Approach To AAV Production 12/7/2023

    How can you face the challenges of AAV production, scale up your AAV manufacturing effectively, and enhance the recovery and purity in your downstream processing.

  5. The Way Forward: Supply Chain Solutions 10/24/2024

    Learn how to build a resilient supply chain to navigate today's complex environment. Expert speakers share insights on optimization, innovation, and strategic planning to meet evolving market conditions.

  6. Advances In Microbial Fermentation Knowledge Culture 6/9/2025

    Presented by three experts, this session examines real-world examples of how different approaches to media formulation and process conditions can influence outcomes.

  7. Bioprocessing Equipment And Automation Product Portfolio Overview 5/19/2025

    Accelerate biotherapeutic development with innovative bioprocessing equipment and automation solutions that feature single-use mixers, bioreactors, and more to streamline workflows and speed products to market.

  8. CTS OpTmizer One SFM: Thoughtfully Designed Nutrition For T Cells 5/22/2025

    Learn about a novel, next-generation medium with an animal-component-free formulation developed to support the need for a T-cell medium that allows consistent, reproducible, and automated T-cell manufacturing.

  9. Understanding AI And Machine Learning's Impact On CGT with Dr. Peter Marks and Dr. Nicole Verdun 1/30/2024

    During this segment, Dr. Peter Marks and Dr. Nicole Verdun share their take on how AI and machine learning will impact FDA regulation in 2024.

  10. What Is The DynaChrom™ Single-Use Chromatography System? 3/21/2024

    This chromatography system offers a flexible solution, paired with an advanced software platform, allowing easy integration with downstream process automation.